Wearable device could predict deadly surgery complications
NCT ID NCT07300579
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
VISION-2 is a large observational study of 20,000 older adults having noncardiac surgery. Participants will wear a continuous vital signs monitor for up to 30 days after surgery. The goal is to find early warning signs of serious complications like heart injury, severe bleeding, and sepsis, and to build prediction models. No new treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a wearable device that warns doctors early about serious complications after surgery, potentially saving lives.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear warning signals, and any future device would need separate testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
-
Juravinski Hospital & Cancer Centre
Hamilton, Ontario, L8V 1C3, Canada
-
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada